Middle East & Africa C-Reactive Protein Testing Market Size & Outlook
- Clinical Diagnostics
- Reagents & Assays
- C-reactive Protein Testing Market Outlook
- Reagents & Assays
Global Market
Related Markets
Ask a question about the c-reactive protein testing market
MEA c-reactive protein testing market highlights
- The MEA c-reactive protein testing market generated a revenue of USD 249.9 million in 2025.
- The market is expected to grow at a CAGR of 1.1% from 2026 to 2033.
- In terms of segment, immunoturbidimetric assay was the largest revenue generating assay type in 2025.
- Immunoturbidimetric assay is the most lucrative assay type segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2026 to 2033.
MEA data book summary
| Market revenue in 2025 | USD 249.9 million |
| Market revenue in 2033 | USD 272.1 million |
| Growth rate | 1.1% (CAGR from 2026 to 2033) |
| Largest segment | Immunoturbidimetric assay |
| Fastest growing segment | Immunoturbidimetric assay |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunoturbidimetric assay, ELISA, Chemiluminescence Immunoassay (CLIA ) |
| Key market players worldwide | Thermo Fisher Scientific Inc, Roche Holding AG ADR, Danaher Corp, Quest Diagnostics Inc, Siemens Healthineers AG ADR, Abbott Laboratories, Merck KGaA, Zoetis Inc Class A, QuidelOrtho Corp, Horiba Ltd, Getein Biotech, Boditech Med, Randox, Aidian |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.7% of the global c-reactive protein testing market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,378.2 million by 2033.
The MEA region held the lowest market share in 2020 owing to factors such as nascent stage healthcare infrastructure and low awareness about POC CRP testing devices. However, rising incidence of various chronic diseases coupled with increasing R&D investigations in the region are expected to drive the market.
Moreover, low availability of advanced diagnostic procedures, underdeveloped healthcare infrastructure, and lack of affordable treatment options make MEA an open field for investments by large manufacturers.
Furthermore, rising prevalence of non-communicable diseases in the region, increasing initiatives being undertaken by the government to reduce incidence of these diseases, and rising awareness are among factors anticipated to fuel market growth.
No credit card required*
Publish Date: Apr 22, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
C-Reactive Protein Testing Market Scope
C-Reactive Protein Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| Zoetis Inc Class A | View profile | 14,100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | www.zoetis.com |
| QuidelOrtho Corp | View profile | 7,100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | www.quidelortho.com |
| Horiba Ltd | View profile | 8,665 | 2, Miyanohigashi-cho, Kisshoin, Minami-ku, Kyoto, Japan, 601-8510 | www.horiba.co.jp |
Middle East & Africa C-reactive Protein Testing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to C-reactive Protein Testing Market Outlook will help companies and investors design strategic landscapes.
Immunoturbidimetric Assay was the largest segment with a revenue share of 48.86% in 2025.
Horizon Databook has segmented the Middle East & Africa c-reactive protein testing market based on immunoturbidimetric assay, elisa, chemiluminescence immunoassay (clia ) covering the revenue growth of each sub-segment from 2021 to 2033.
The MEA region held the lowest market share in 2020 owing to factors such as nascent stage healthcare infrastructure and low awareness about POC CRP testing devices. However, rising incidence of various chronic diseases coupled with increasing R&D investigations in the region are expected to drive the market.
Moreover, low availability of advanced diagnostic procedures, underdeveloped healthcare infrastructure, and lack of affordable treatment options make MEA an open field for investments by large manufacturers.
Furthermore, rising prevalence of non-communicable diseases in the region, increasing initiatives being undertaken by the government to reduce incidence of these diseases, and rising awareness are among factors anticipated to fuel market growth.
- Middle East & Africa C-Reactive Protein Testing Market Assay Type Outlook (Revenue, USD Million , 2021-2033)
- Immunoturbidimetric assay
- ELISA
- Chemiluminescence Immunoassay (CLIA )
- Others
- Middle East & Africa C-Reactive Protein Testing Market Detection range Outlook (Revenue, USD Million , 2021-2033)
- hs-CRP
- Conventional CRP
- cCRP
- Middle East & Africa C-Reactive Protein Testing Market Disease type Outlook (Revenue, USD Million , 2021-2033)
- Cardiovascular Diseases
- Cancer
- Rheumatoid arthritis
- Inflammatory bowel disease
- Endometriosis
- Lupus
- Others
- Middle East & Africa C-Reactive Protein Testing Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Clinics
- Hospitals
- Laboratories
- Assisted Living Healthcare Facilities
- Home
- Others
Reasons to subscribe to C-reactive Protein Testing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of C-reactive Protein Testing Market Outlook databook
- Our clientele includes a mix of C-reactive Protein Testing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa C-reactive Protein Testing Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa C-reactive Protein Testing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Middle East Africa C-Reactive Protein Testing Market, 2021-2033 (US$M)
MEA c-reactive protein testing market statistics, by assay type, 2021-2033 (US$M)
